Synedgen to Partner with the NIH for Radiation Countermeasures Product…
Synedgen Active Agent SY303A will undergo Further Non-Clinical Efficacy Testing at the Armed Forces Radiobiology Research Institute (AFRRI), in Bethesda, Maryland
(PRWeb November 14, 2012)
Read the full story at http://www.prweb.com/releases/2012/11/prweb10130299.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.